Phase 4 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years of age
- People who have been diagnosed with rheumatoid arthritis (RA) based on recognised international diagnostic guidelines (ACR/EULAR 2010 criteria)
- People whose rheumatoid arthritis has been in remission (very low disease activity) for at least 6 months, based on a specific scoring measure called DAS28 (a score of 2.6 or below)
- People who have been receiving a medication called adalimumab (ADA) at 40mg for at least 6 months, either every 2 weeks or every 3 weeks
- Women who could become pregnant must have a negative highly sensitive pregnancy test at the time of joining
- People who are covered by a social security or health insurance scheme
- People who have read the study information and signed a consent form agreeing to take part
Who may not be able to join:
- People who are unable to understand the study information, or who do not wish to sign the consent form
- People who are currently pregnant, breastfeeding, or planning to become pregnant within the next 15 months
- People who have both rheumatoid arthritis and a condition called fibromyalgia at the same time
- People who have taken any dose of prednisone (a corticosteroid medication) for their rheumatoid arthritis in the 6 months before joining the trial
- People who are in legal custody, or whose legal decision-making is managed by a guardian or appointed caretaker
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (0)4 77 12 76 49
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rheumatoid arthritis flare-up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.